In a study published in the ASAIO Journal by Erica C. Perez and colleagues, researchers validated the Harvi cardiovascular simulation platform as a reliable tool for predicting the effects of a novel non-blood-contacting direct cardiac compression (DCC) device developed by CorInnova.The innovative device functions by repeatedly compressing the ventricles in step with the heartbeat, providing…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest
Sponsored Links
